Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can simple seated exercises boost strength and Well-Being during leukemia treatment?

NCT ID NCT07740174

Symptom relief Sponsor: Suez University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This trial tests whether a structured seated exercise program can help men with leukemia maintain functional capacity and quality of life during chemotherapy. Participants will do supervised, moderate-intensity seated exercises during their chemo cycles, with outcomes measured by walking tests, lung function, and a quality-of-life questionnaire. The goal is to see if this gentle exercise approach can ease the physical toll of treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured seated exercise program
What this could lead to
If effective, this could offer a simple, safe way to help leukemia patients maintain physical function and feel better during chemotherapy.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply broadly. Exercise during chemo may be challenging for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 40 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male patients with age ranges from 30 to 40 years. 2. All patients in this study will be on chemotherapy from at least one cycle as a treatment of leukemia. 3. All patients will be hemodynamically stable. 4. Patients are ambulant. Exclusion Criteria: 1. Lung cancer 2. History of any pulmonary disease. 3. Metastasis of lung , ribs and mediastinal structure. 4. Pulmonary pathology (e.g. acute respiratory distress syndrome, or exacerbation of chronic obstructive pulmonary disease). 5. Ruptured eardrum or any other condition of the ear. 6. Severe bronchospasm. 7. High peak air way pressure (barotraumas). 8. patients with marked elevated left ventricular end- diastolic volume and pressure. 9. patients with worsening haert failure signs and symptoms.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Leukemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Leukemia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.